PARP1 has been shown to bind to KSHV’s terminal repeat sequence (which, during latent infection, functions as an origin of replication) and PARylate the latency-associated nuclear antigen associated with the terminal repeat sequence during latent infection [85]. This evidence concerns the gene PARP1 and disease arising from reactivation of latent virus.